Article
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
29 Aug 2015
Abstract excerpt
Fetal hemoglobin (HbF, α2γ2) induction is a well-validated strategy for sickle cell disease (SCD) treatment. Using a small-molecule screen, we found that UNC0638, a selective inhibitor of EHMT1 and EHMT2 histone methyltransferases, induces γ-globin expression. EHMT1/2 catalyze mono- and dimethylation of lysine 9 on histone 3 (H3K9), raising the possibility that H3K9Me2, a repressive chromatin mark, plays a role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
